Literature DB >> 28233923

Axon contact-driven Schwann cell dedifferentiation.

Jennifer Soto1, Paula V Monje1.   

Abstract

Mature Schwann cells (SCs) retain dedifferentiation potential throughout adulthood. Still, how dedifferentiation occurs remains uncertain. Results from a variety of cell-based assays using in vitro cultured cAMP-differentiated and myelinating SCs revealed the existence of a novel dedifferentiating activity expressed on the surface of dorsal root ganglion (DRG) axons. This activity had the capacity to prevent SC differentiation and elicit dedifferentiation through direct SC-axon contact. Evidence is provided showing that a rapid loss of myelinating SC markers concomitant to proliferation occurred even in the presence of elevated cAMP, a signal that is required to drive and maintain a differentiated state. The dedifferentiating activity was a membrane-bound protein found exclusively in DRG neurons, as judged by its subcellular partitioning, sensitivity to proteolytic degradation and cell-type specificity, and remained active even after disruption of cellular organization. It differed from the membrane-anchored neuregulin-1 isoforms that are responsible for axon contact-induced SC proliferation and exerted its action independently of mitogenic signaling emanating from receptor tyrosine kinases and mitogen-activated protein kinases such as ERK and JNK. Interestingly, dedifferentiation occurred without concomitant changes in the expression of Krox-20, a transcriptional enhancer of myelination, and c-Jun, an inhibitor of myelination. In sum, our data indicated the existence of cell surface axon-derived signals that override pro-differentiating cues, drive dedifferentiation and allow SCs to proliferate in response to axonal mitogens. This axonal signal may negatively regulate myelination at the onset or reversal of the differentiated state. GLIA 2017;65:851-863.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cAMP; cell signaling; cell-cell interactions; differentiation; dorsal root ganglion neurons; in vitro systems; myelination; proliferation

Mesh:

Substances:

Year:  2017        PMID: 28233923      PMCID: PMC5395415          DOI: 10.1002/glia.23131

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  31 in total

1.  Schwann cell dedifferentiation is independent of mitogenic signaling and uncoupled to proliferation: role of cAMP and JNK in the maintenance of the differentiated state.

Authors:  Paula V Monje; Jennifer Soto; Ketty Bacallao; Patrick M Wood
Journal:  J Biol Chem       Date:  2010-07-15       Impact factor: 5.157

2.  Microanatomy of axon/glial signaling during Wallerian degeneration.

Authors:  Amy D Guertin; Dan P Zhang; Kimberley S Mak; John A Alberta; Haesun A Kim
Journal:  J Neurosci       Date:  2005-03-30       Impact factor: 6.167

3.  Schwann cells degrade myelin and proliferate in the absence of macrophages: evidence from in vitro studies of Wallerian degeneration.

Authors:  C Fernandez-Valle; R P Bunge; M B Bunge
Journal:  J Neurocytol       Date:  1995-09

4.  Neuregulin isoforms in dorsal root ganglion neurons: effects of the cytoplasmic domain on localization and membrane shedding of Nrg-1 type I.

Authors:  Zhiyou Zhang; Lisa Prentiss; Deborah Heitzman; Richard C Stahl; Frank DiPino; David J Carey
Journal:  J Neurosci Res       Date:  2006-07       Impact factor: 4.164

Review 5.  Neurofibroma development in NF1--insights into tumour initiation.

Authors:  Simona Parrinello; Alison C Lloyd
Journal:  Trends Cell Biol       Date:  2009-07-15       Impact factor: 20.808

6.  A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma.

Authors:  Hiroyuki Kato; Tatsuya Miyazaki; Yasuyuki Fukai; Masanobu Nakajima; Makoto Sohda; Junko Takita; Norihiro Masuda; Minoru Fukuchi; Ryokuhei Manda; Hitoshi Ojima; Katsuhiko Tsukada; Takayuki Asao; Hiroyuki Kuwano
Journal:  J Surg Oncol       Date:  2003-09       Impact factor: 3.454

Review 7.  Negative regulation of myelination: relevance for development, injury, and demyelinating disease.

Authors:  Kristján R Jessen; Rhona Mirsky
Journal:  Glia       Date:  2008-11-01       Impact factor: 8.073

Review 8.  The repair Schwann cell and its function in regenerating nerves.

Authors:  K R Jessen; R Mirsky
Journal:  J Physiol       Date:  2016-03-21       Impact factor: 5.182

9.  Krox-20 controls myelination in the peripheral nervous system.

Authors:  P Topilko; S Schneider-Maunoury; G Levi; A Baron-Van Evercooren; A B Chennoufi; T Seitanidou; C Babinet; P Charnay
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

10.  Studies of Schwann cell proliferation. III. Evidence for the surface localization of the neurite mitogen.

Authors:  J L Salzer; R P Bunge; L Glaser
Journal:  J Cell Biol       Date:  1980-03       Impact factor: 10.539

View more
  6 in total

1.  Phenotypic and Functional Characteristics of Human Schwann Cells as Revealed by Cell-Based Assays and RNA-SEQ.

Authors:  Paula V Monje; David Sant; Gaofeng Wang
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

2.  Systemic loss of Sarm1 protects Schwann cells from chemotoxicity by delaying axon degeneration.

Authors:  Weili Tian; Tim Czopka; Hernán López-Schier
Journal:  Commun Biol       Date:  2020-01-30

3.  Protective effects and molecular mechanisms of Achyranthes bidentata polypeptide k on Schwann cells.

Authors:  Meiyuan Li; Ye Zhu; Leili Tang; Hua Xu; Jingfei Zhong; Wenqiang Peng; Ying Yuan; Xiaosong Gu; Hongkui Wang
Journal:  Ann Transl Med       Date:  2021-03

4.  HIV-1 gp120 Promotes Lysosomal Exocytosis in Human Schwann Cells.

Authors:  Gaurav Datta; Nicole M Miller; Zahra Afghah; Jonathan D Geiger; Xuesong Chen
Journal:  Front Cell Neurosci       Date:  2019-07-17       Impact factor: 5.505

Review 5.  Schwann Cell Cultures: Biology, Technology and Therapeutics.

Authors:  Paula V Monje
Journal:  Cells       Date:  2020-08-06       Impact factor: 6.600

6.  Tacrolimus-Induced Neurotrophic Differentiation of Adipose-Derived Stem Cells as Novel Therapeutic Method for Peripheral Nerve Injury.

Authors:  Xiangyun Yao; Zhiwen Yan; Xiaojing Li; Yanhao Li; Yuanming Ouyang; Cunyi Fan
Journal:  Front Cell Neurosci       Date:  2021-12-08       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.